Alimentary pharmacology & therapeutics
Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non-Lean Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Shinya Yokoyama, Takanori Ito
Published: 202510.1111/apt.70451
No abstract available for this study.